Detection and Characterization of Thrombosis in Humans Using Fibrin-Targeted Positron Emission Tomography and Magnetic Resonance
Overview
Radiology
Authors
Affiliations
Objectives: The authors present a novel technique to detect and characterize LAA thrombus in humans using combined positron emission tomography (PET)/cardiac magnetic resonance (CMR) of a fibrin-binding radiotracer, [Cu]FBP8.
Background: The detection of thrombus in the left atrial appendage (LAA) is vital in the prevention of stroke and is currently performed using transesophageal echocardiography (TEE).
Methods: The metabolism and pharmacokinetics of [Cu]FBP8 were studied in 8 healthy volunteers. Patients with atrial fibrillation and recent TEEs of the LAA (positive n = 12, negative n = 12) were injected with [Cu]FBP8 and imaged with PET/CMR, including mapping the longitudinal magnetic relaxation time (T) in the LAA.
Results: [Cu]FBP8 was stable to metabolism and was rapidly eliminated. The maximum standardized uptake value (SUV) in the LAA was significantly higher in the TEE-positive than TEE-negative subjects (median of 4.0 [interquartile range (IQR): 3.0-6.0] vs 2.3 [IQR: 2.1-2.5]; P < 0.001), with an area under the receiver-operating characteristic curve of 0.97. An SUV threshold of 2.6 provided a sensitivity of 100% and specificity of 84%. The minimum T (T) in the LAA was 970 ms (IQR: 780-1,080 ms) vs 1,380 ms (IQR: 1,120-1,620 ms) (TEE positive vs TEE negative; P < 0.05), with some overlap between the groups. Logistic regression using SUV and T allowed all TEE-positive and TEE-negative subjects to be classified with 100% accuracy.
Conclusions: PET/CMR of [Cu]FBP8 is able to detect acute as well as older platelet-poor thrombi with excellent accuracy. Furthermore, the integrated PET/CMR approach provides useful information on the biological properties of thrombus such as fibrin and methemoglobin content. (Imaging of LAA Thrombosis; NCT03830320).
Torralba-Maldonado D, Marlin A, Lucio-Martinez F, Freire-Garcia A, Whetter J, Brandariz I Inorg Chem. 2024; 63(46):22297-22307.
PMID: 39508185 PMC: 11577316. DOI: 10.1021/acs.inorgchem.4c04050.
Non-invasive in vivo imaging of changes in Collagen III turnover in myocardial fibrosis.
Chaher N, Lacerda S, Digilio G, Padovan S, Gao L, Lavin B Npj Imaging. 2024; 2(1):33.
PMID: 39301014 PMC: 11408249. DOI: 10.1038/s44303-024-00037-z.
Epshtein M, Gounis M, Bogdanov Jr A ACS Omega. 2024; 9(27):29391-29400.
PMID: 39005803 PMC: 11238305. DOI: 10.1021/acsomega.4c01525.
Dosimetry of [Cu]FBP8: a fibrin-binding PET probe.
Izquierdo-Garcia D, Desogere P, Philip A, Sosnovik D, Catana C, Caravan P medRxiv. 2024; .
PMID: 38978675 PMC: 11230308. DOI: 10.1101/2024.06.27.24309589.
Munchel J, Misra A, Collins S, DiGregorio R, Palmisciano A, Heidari P Am J Respir Crit Care Med. 2024; 210(4):514-517.
PMID: 38843499 PMC: 11351804. DOI: 10.1164/rccm.202312-2357LE.